Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 1026 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1026 DOIs

Deposit reference lists for 792 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact792 DOIs

Add license metadata to 180 records

License metadata tells indexers and readers how each article may be reused.

Low impact180 DOIs

DOIs for this ISSN

Showing the top 5 of 1799 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Characteristic gut microbiota and predicted metabolic functi… (10.1530/ec-19-0522)	References ORCID License	157.27	124
2	Management of endocrine immune-related adverse events of imm… (10.1530/ec-20-0342)	References ORCID License	153.98	112
3	Anabolic androgenic steroid abuse in young males (10.1530/ec-19-0557)	References ORCID License	150.00	99
4	Obesity and endocrine-disrupting chemicals (10.1530/ec-20-0578)	References ORCID License	146.57	89
5	SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emer… (10.1530/ec-16-0054)	Abstract References ORCID	144.71	84
6	FGF21 regulates hepatic metabolic pathways to improve steato… (10.1530/ec-20-0152)	References ORCID License	142.73	79
7	Pathophysiology of NASH in endocrine diseases (10.1530/ec-20-0490)	References ORCID License	136.47	65
8	Pregnancy and lactation, a challenge for the skeleton (10.1530/ec-20-0055)	References ORCID License	135.97	64
9	Approach to patients with pseudo-Cushing’s states (10.1530/ec-19-0435)	References ORCID License	135.46	63
10	Why do so many trials of vitamin D supplementation fail? (10.1530/ec-20-0274)	References ORCID License	134.95	62
11	Mitochondrial dysfunction and insulin resistance: an update (10.1530/ec-14-0092)	References ORCID	132.95	455
12	Female hyperandrogenism and elite sport (10.1530/ec-19-0537)	References ORCID License	131.69	56
13	SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emer… (10.1530/ec-16-0057)	Abstract References ORCID	131.11	55
14	Thyroid hormones in the regulation of brown adipose tissue t… (10.1530/ec-20-0562)	References ORCID License	130.53	54
15	SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emer… (10.1530/ec-16-0056)	Abstract References ORCID	129.32	52
16	Risk factors and management of pasireotide-associated hyperg… (10.1530/ec-20-0361)	References ORCID License	128.70	51
17	SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emer… (10.1530/ec-16-0055)	Abstract References ORCID	128.07	50
18	Changes in clinical and biochemical characteristics of polyc… (10.1530/ec-19-0496)	References ORCID License	128.07	50
19	Exercise and insulin resistance in PCOS: muscle insulin sign… (10.1530/ec-19-0551)	References ORCID License	128.07	50
20	177Lu-DOTATATE therapy in metastatic/inoperable pheochromocy… (10.1530/ec-20-0292)	References ORCID License	128.07	50
21	Increased prevalence of overweight and obesity in children w… (10.1530/ec-19-0481)	References ORCID License	127.42	49
22	Traumatic brain injuries induced pituitary dysfunction: a ca… (10.1530/ec-20-0117)	References ORCID License	126.09	47
23	Klinefelter syndrome and testosterone treatment: a national… (10.1530/ec-19-0433)	References ORCID License	123.99	44
24	Therapeutic management of hypophosphatemic rickets from infa… (10.1530/ec-13-0103)	References ORCID	123.78	298
25	Phenomenon of osteocyte lacunar mineralization: indicator of… (10.1530/ec-19-0531)	References ORCID License	122.51	42
26	SST5 expression and USP8 mutation in functioning and silent… (10.1530/ec-20-0035)	References ORCID License	120.15	39
27	Long-term efficacy of metformin in overweight-obese PCOS: lo… (10.1530/ec-19-0449)	References ORCID License	119.33	38
28	Clinical guidelines for burosumab in the treatment of XLH in… (10.1530/ec-20-0291)	References ORCID License	118.48	37
29	Denosumab for management of severe hypercalcemia in primary… (10.1530/ec-20-0380)	References ORCID License	118.48	37
30	Effects of oral contraceptives on metabolic parameters in ad… (10.1530/ec-20-0423)	References ORCID License	117.62	36
31	Cinacalcet and primary hyperparathyroidism: systematic revie… (10.1530/ec-20-0221)	References ORCID License	116.72	35
32	Primary hyperparathyroidism as first manifestation in multip… (10.1530/ec-20-0163)	References ORCID License	115.81	34
33	IGF1 for the diagnosis of growth hormone deficiency in child… (10.1530/ec-20-0347)	References ORCID License	115.81	34
34	Higher blood pressure in normal weight women with PCOS compa… (10.1530/ec-20-0527)	References ORCID License	115.81	34
35	Association between frailty and risk of fall among diabetic… (10.1530/ec-20-0405)	References ORCID License	114.86	33
36	The metabolic benefits of different bariatric operations: wh… (10.1530/ec-19-0467)	References ORCID License	113.89	32
37	Impact of hyperthyroidism on cardiac hypertrophy (10.1530/ec-19-0543)	References ORCID License	113.89	32
38	Sensitivity and specificity of the macimorelin test for diag… (10.1530/ec-20-0491)	References ORCID License	112.89	31
39	The appraisal of chronic stress and the development of the m… (10.1530/ec-14-0031)	References ORCID	111.90	172
40	Metformin decreases miR-122, miR-223 and miR-29a in women wi… (10.1530/ec-20-0195)	References ORCID License	111.85	30
41	Diagnostic testing of autonomous cortisol secretion in adren… (10.1530/ec-20-0419)	References ORCID License	111.85	30
42	Noninvasive follicular thyroid neoplasm with papillary-like… (10.1530/ec-19-0566)	References ORCID License	110.78	29
43	Improvement of skeletal muscle insulin sensitivity by 1 week… (10.1530/ec-20-0082)	References ORCID License	110.78	29
44	SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emer… (10.1530/ec-16-0058)	Abstract References ORCID	109.68	28
45	Myo-inositol effects in women with PCOS: a meta-analysis of… (10.1530/ec-17-0243)	References ORCID	109.09	151
46	Gut microbiota and diet in patients with different glucose t… (10.1530/ec-15-0094)	References ORCID	108.95	150
47	Two distinct clinical patterns of checkpoint inhibitor-induc… (10.1530/ec-19-0473)	References ORCID License	108.54	27
48	Association between dietary calcium intake and BMD in childr… (10.1530/ec-19-0534)	References ORCID License	108.54	27
49	The impact of endocrine disruptor chemicals on oocyte/embryo… (10.1530/ec-20-0135)	References ORCID License	108.54	27
50	Sexual dimorphism in insulin resistance in a metabolic syndr… (10.1530/ec-20-0288)	References ORCID License	107.35	26